An update on the role of miR-379 in human disorders
Tài liệu tham khảo
Glazov, 2008, Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals, Mol. Biol. Evol., 25, 939, 10.1093/molbev/msn045
Seitz, 2004, A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain, Genome Res., 14, 1741, 10.1101/gr.2743304
Fiore, 2009, Mef2–mediated transcription of the miR379–410 cluster regulates activity‐dependent dendritogenesis by fine‐tuning Pumilio2 protein levels, EMBO J., 28, 697, 10.1038/emboj.2009.10
Guia, 2015, microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis, EMBO J., 34, 344, 10.15252/embj.201490464
Sanson, 2020, miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy, Sci. Rep., 10, 1, 10.1038/s41598-020-66016-7
Marty, 2016, Deletion of the miR-379/miR-410 gene cluster at the imprinted Dlk1-Dio3 locus enhances anxiety-related behaviour, Hum. Mol. Genet., 25, 728, 10.1093/hmg/ddv510
Labialle, 2014, The miR‐379/miR‐410 cluster at the imprinted Dlk1–Dio3 domain controls neonatal metabolic adaptation, EMBO J., 33, 2216, 10.15252/embj.201387038
Nayak, 2018, Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma, Sci. Rep., 8, 1, 10.1038/s41598-018-26000-8
Kumar, 2018, Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas, J. Neuro Oncol., 139, 23, 10.1007/s11060-018-2840-6
Wei, 2019, MicroRNA‐379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF‐4, Kaohsiung J. Med. Sci., 35, 731, 10.1002/kjm2.12109
Zhang, 2020, MicroRNA-379-5p/YBX1 axis regulates cellular EMT to suppress migration and invasion of nasopharyngeal carcinoma cells, Cancer Manag. Res., 12, 4335, 10.2147/CMAR.S253504
Guo, 2020, Circ_0011292 enhances paclitaxel resistance in non-small cell lung cancer by regulating miR-379-5p/TRIM65 axis, Cancer Biother. Radiopharm., 10.1089/cbr.2019.3546
Jiang, 2020, miR‑379–5p inhibits cell proliferation and promotes cell apoptosis in non‑small cell lung cancer by targeting β‑arrestin‑1, Mol. Med. Rep., 22, 4499, 10.3892/mmr.2020.11553
Zhou, 2017, MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways., Oncol. Rep., 38, 1857, 10.3892/or.2017.5835
Jun, 2020, Circ_SIPA1L1 promotes osteosarcoma progression via miR-379-5p/MAP3K9 Axis, Cancer Biother. Radiopharm., 10.1089/cbr.2020.3891
Xie, 2017, MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2, Biosci. Rep., 37, 10.1042/BSR20160542
Li, 2017, Micro RNA‐379 suppresses osteosarcoma progression by targeting PDK 1, J. Cell. Mol. Med., 21, 315, 10.1111/jcmm.12966
Ji, 2020, LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis, Cell Death Dis., 11, 1, 10.1038/s41419-019-2213-x
Khan, 2013, miR-379 regulates cyclin B1 expression and is decreased in breast cancer, PloS One, 8, 10.1371/journal.pone.0068753
O’brien, 2018, Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379, Oncogene, 37, 2137, 10.1038/s41388-017-0116-9
Chen, 2016, MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma, Cancer Lett., 375, 73, 10.1016/j.canlet.2016.02.043
Yamamoto, 2014, MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma, Oncol. Rep., 32, 2365, 10.3892/or.2014.3481
Xu, 2017, MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer, Int. J. Oncol., 51, 867, 10.3892/ijo.2017.4072
Gururajan, 2014, miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer, Clin. Cancer Res., 20, 6559, 10.1158/1078-0432.CCR-14-1784
Wu, 2017, MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2, Oncol. Rep., 37, 3502, 10.3892/or.2017.5607
Wang, 2020, MiR-379 inhibits proliferation and induces apoptosis in multiple myeloma by targeting Y-box binding protein 1, Trop. J. Pharm. Res., 19, 1843, 10.4314/tjpr.v19i9.7
Li, 2019, Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells, Metallomics, 11, 483, 10.1039/C8MT00321A
Dang, 2018, MicroRNA-379-5p is associated with biochemical premature ovarian insufficiency through PARP1 and XRCC6, Cell Death Dis., 9, 1, 10.1038/s41419-017-0163-8
Jee, 2018, Mir-374-5p, mir-379-5p, and mir-503-5p regulate proliferation and hypertrophic differentiation of growth plate chondrocytes in male rats, Endocrinology, 159, 1469, 10.1210/en.2017-00780
Guia, 2015, micro RNA‐379 couples glucocorticoid hormones to dysfunctional lipid homeostasis, EMBO J., 34, 344, 10.15252/embj.201490464
Werk, 2014, Genetic variants may play an important role in mRNA–miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379, Pharm. Genom., 24, 283, 10.1097/FPC.0000000000000046
Haenisch, 2011, Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379, Mol. Pharmacol., 80, 314, 10.1124/mol.110.070714
Li, 2017, miR-379 inhibits cell proliferation, invasion, and migration of vascular smooth muscle cells by targeting insulin-like factor-1, Yonsei Med. J., 58, 234, 10.3349/ymj.2017.58.1.234
Liu, 2020, MicroRNA‐379 mediates pigmentation, migration and proliferation of melanocytes by targeting the insulin‐like growth factor 1 receptor, Exp. Dermatol., 29, 467, 10.1111/exd.14095
Gao, 2015, Regulation of DLK1 by the maternally expressed miR-379/miR-544 cluster may underlie callipyge polar overdominance inheritance, Proc. Natl. Acad. Sci., 112, 13627, 10.1073/pnas.1511448112
Okamoto, 2020, Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease, PloS One, 15, 10.1371/journal.pone.0219412